Proximagen to be acquired by Upsher-Smith Laboratories

Proximagen Group Plc, a 2003 spin-out of King’s College London with an early-stage portfolio of treatments for central nervous system disorders, is to be acquired for up to £356.8 by Upsher-Smith Laboratories Inc of the US.